Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06854406 · ClinicalTrials.gov registry record · Phase 1
A Study of Varenicline in the Treatment of Visceral Sensation
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT06854406: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT06854406 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06854406, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of varenicline on rectal sensation, based on ascending method of limits and on graded rapid phasic distensions in participants with non-constipation IBS and chronic abdominal pain.
Interventions
- DRUG Varenicline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2025-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06854406
The ClinicalTrials.gov registry entry for NCT06854406 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Varenicline is the first listed.
NCT06854406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06854406 about?
NCT06854406 is a clinical study titled "A Study of Varenicline in the Treatment of Visceral Sensation". The purpose of this study is to evaluate the effect of varenicline on rectal sensation, based on ascending method of limits and on graded rapid phasic distensions in participants with non-constipation IBS and chronic abdominal pain.
What is the current status of trial NCT06854406?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2025-06-01. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT06854406?
The interventions under investigation include: Varenicline (DRUG).
Who is sponsoring clinical trial NCT06854406?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.